Latest Articles

All News Scientific

Endometrial Cancer: Sequencing Lenvatinib–Pembrolizumab - Alignment with Trials, Post-Adjuvant Potential, and Dose Flexibility - OncLive

Endometrial Cancer: Sequencing Lenvatinib–Pembrolizumab - Alignment with Trials, Post-Adjuvant Potential, and Dose Flexibility OncLive

Published: Jan. 2, 2026, 1:12 p.m.

Read Full Article

Link copied to clipboard!